IRTC — iRhythm Holdings Share News
0.000.00%
Last trade - 00:00- $4.21bn
- $4.27bn
- $747.14m
Needham raises PT on iRhythm Technologies
U.S. RESEARCH ROUNDUP- BlackRock, Cencora, UnitedHealth
U.S. RESEARCH ROUNDUP-Allstate, Brinker International, Meta
iRhythm Technologies Inc reports results for the quarter ended in January 1 - Earnings Summary
Brief: iRhythm Technologies Q3 Revenue USD 147.5 Million Vs. IBES Estimate USD 146.7 Million
Brief: Irhythm Technologies Receives FDA 510(K) Clearance For Design Updates To Its Zio® AT Device
U.S. RESEARCH ROUNDUP-Fox Corp, Smartsheet, Tesla
Brief: iRhythm Technologies Received Regulatory Approval From Japanese Pharmaceutical & Medical Device Agency For Zio 14-Day ECG Monitoring System
Brief: iRhythm Technologies Under License Agreement with Biointellisense, To Pay Biois Upfront Fee Of $15 Mln In Cash
Brief: Irhythm Technologies Enters License Agreement With Biointellisense For Multiparameter Sensor Technology To Be Used In Ambulatory Cardiac Monitoring
U.S. RESEARCH ROUNDUP-Apple, Centerpoint Energy, Cummins
iRhythm Technologies Inc reports results for the quarter ended in June - Earnings Summary
Brief: iRhythm Technologies Q2 Revenue USD 148 Million Vs. IBES Estimate USD 146.2 Million
iRhythm Technologies Inc expected to post a loss of 89 cents a share - Earnings Preview
iRhythm Technologies Inc reports results for the quarter ended in March - Earnings Summary
Brief: iRhythm Technologies Q1 Revenue USD 131.9 Million Vs. IBES Estimate USD 128.4 Million
iRhythm Technologies Inc expected to post a loss of 98 cents a share - Earnings Preview
Brief: Irhythm Prices Upsized Offering Of $575.0 Million Of 1.50% Convertible Senior Notes Due 2029
iRhythm Technologies slides on planned convertible offering